Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Coordination and Support Action · Running

InnovAntiBiofilm Boosting Sustainable Innovation in Developing New Antibiotic Adjuvants to Control Biofilm Resistance

Coordinator
Universidade Do Porto, Portugal
Runs
1 October 2024 to 30 September 2027
Status
Running
EU funding
€1.5m
Total cost
—
Partners
4 organisations in 3 countries
Type
Coordination and Support Action
Grant agreement
101157363

What the project is doing

In the project's own words, from its summary on CORDIS.

InnovAntiBiofilm will revolve around the subject matter of sustainable development of new adjuvant agents to boost the action of antibiotics against biofilm infections. This will be achieved through the sustainable biosynthesis of plant molecules and the rational development of derivatives. These scientific activities, together with capacity building and networking activities, talent development of young researchers, mentoring, inclusiveness, and strengthening research management and administration skills, will be at the crux of the project concept.

This will be achieved by Twinning UPORTO with truly outstanding EU institutions with recognised expertise in the areas of medicinal and combinatorial chemistry (CEA), metabolic and bioprocess engineering (Fraunhofer-IME), and R&I management, access to funding and links with industry (KPMG). These internationally-leading partners will provide decisive expertise to capacitate UPORTO on the heterologous biosynthesis of phytochemicals and development of innovative phytochemical derivatives with improved antibiotic adjuvant action for biofilm control, as well as to strengthen UPORTO’s R&D competitiveness and administrative skills.

The objectives of InnovAntiBiofilm are in line with the specific challenge and scope of the topic HORIZON-WIDERA-2023-ACCESS-02-01 of the Twinning call, addressing networking gaps and deficiencies between the research institutions of the Widening countries and internationally-leading counterparts at EU level. InnovAntiBiofilm will allow the development of a consolidated strategic research approach and a set of guidelines for exploitation and commercialisation of the results that will have a strong regional, national and European impact.

The project integrates synergies in complementary fields of research that include biotechnology, microbiology, synthetic chemistry and pharmacognosy, aiming to obtain scientific breakthroughs that can improve global health and economy.

Topics

Who is involved

OrganisationCityCountryRole
Universidade Do PortoPortoPortugalCoordinator
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Commissariat a L Energie Atomique Et Aux Energies AlternativesParisFranceParticipant
Kpmg & Associados Sociedade De Revisores Oficias De Contas SALisbonPortugalParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI